Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncology Group Kidney Cancer Consortium

发表于 2026-9-16 10:13:43

期刊：Therapeutic Advances in Medical Oncology

文献作者：Musa Baris Aykan; Hatice Bolek; Emre Yekedüz; Elif Sertesen; Deniz Tural; Cengiz Karacin; Mehmet Ali Nahit Sendur; Gokhan Ucar; Cagatay Arslan; Selver Isik; Saadet Sim; Ozlem Nuray Sever; Bekir Hacioglu; Sema Sezgin Goksu; Mustafa Ozgüroglu; Nuri Karadurmus; Yüksel Urün

出版日期：2025-1-

DOI号：10.1177/17588359251331540

下载链接：https://journals.sagepub.com/doi/pdf/10.1177/17588359251331540

文献链接：https://doi.org/10.1177/17588359251331540

当前文献来源于 SAGE Publications。

备注信息：

发表于 2026-9-16 10:13:44

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Sage] Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncology Group Kidney Cancer Consortium

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Sage] Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncology Group Kidney Cancer Consortium 一键复制